IL-2– and IL-15–induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytes

Michał Marzec(University of Pennsylvania), Mariusz A. Wasik(University of Pennsylvania)

Blood

November 20, 2007

10.1182/blood-2007-06-095182

Cited by 74

Related Papers

Activation of Mammalian Target of Rapamycin in Transformed B Lymphocytes Is Nutrient Dependent but Independent of Akt, Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase, Insulin Growth Factor-I, and Serum

|Cancer Research|2005|72

Expression and Oncogenic Role of Brk (PTK6/Sik) Protein Tyrosine Kinase in Lymphocytes

|American Journal Of Pathology|2006|53

Cutting Edge: ROR1/CD19 Receptor Complex Promotes Growth of Mantle Cell Lymphoma Cells Independently of the B Cell Receptor–BTK Signaling Pathway

|The Journal of Immunology|2019|41

The Potent Oncogene NPM-ALK Mediates Malignant Transformation of Normal Human CD4+ T Lymphocytes

|American Journal Of Pathology|2013|37

Activation of mTORC1 Signaling Pathway in AIDS-Related Lymphomas

|American Journal Of Pathology|2009|17